140 related articles for article (PubMed ID: 8789607)
61. Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia.
Dempsey RJ; Roy MW; Meyer K; Cowen DE; Tai HH
J Neurosurg; 1986 Jan; 64(1):118-24. PubMed ID: 3001248
[TBL] [Abstract][Full Text] [Related]
62. Relationship of glucocorticoid suppression of arachidonic acid metabolism to alteration of neutrophil function.
Webb DS; Roth JA
J Leukoc Biol; 1987 Feb; 41(2):156-64. PubMed ID: 3027218
[TBL] [Abstract][Full Text] [Related]
63. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
64. Modulation of arachidonic acid distribution by conjugated linoleic acid isomers and linoleic acid in MCF-7 and SW480 cancer cells.
Miller A; Stanton C; Devery R
Lipids; 2001 Oct; 36(10):1161-8. PubMed ID: 11768161
[TBL] [Abstract][Full Text] [Related]
65. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
66. Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation.
Adachi T; Nakashima S; Saji S; Nakamura T; Nozawa Y
Hepatology; 1995 Jun; 21(6):1668-74. PubMed ID: 7539396
[TBL] [Abstract][Full Text] [Related]
67. [Inhibition of arachidonic acid-induced ear edema in the mouse with lipoxygenase-, cyclo-oxygenase- and dual inhibitors].
Zarnack S; Bekemeier H; Giessler AJ
Pharmazie; 1988 May; 43(5):337-8. PubMed ID: 3140256
[TBL] [Abstract][Full Text] [Related]
68. Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.
Wagenknecht B; Gulbins E; Lang F; Dichgans J; Weller M
FEBS Lett; 1997 Jun; 409(1):17-23. PubMed ID: 9199495
[TBL] [Abstract][Full Text] [Related]
69. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G
J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659
[TBL] [Abstract][Full Text] [Related]
70. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors.
Schulz R; Seeger W
Biochem Pharmacol; 1986 Jan; 35(2):183-93. PubMed ID: 3002385
[TBL] [Abstract][Full Text] [Related]
71. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
Grimminger F; Hattar K; Papavassilis C; Temmesfeld B; Csernok E; Gross WL; Seeger W; Sibelius U
J Exp Med; 1996 Oct; 184(4):1567-72. PubMed ID: 8879231
[TBL] [Abstract][Full Text] [Related]
72. Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools.
Fonteh AN
Eur J Biochem; 2002 Aug; 269(15):3760-70. PubMed ID: 12153573
[TBL] [Abstract][Full Text] [Related]
73. Inactivation of soybean lipoxygenase by lipoxygenase inhibitors in the presence of 15-hydroperoxyeicosatetraenoic acid.
Reynolds CH
Biochem Pharmacol; 1988 Dec; 37(23):4531-7. PubMed ID: 3144281
[TBL] [Abstract][Full Text] [Related]
74. The influence of some 3-amino-2-pyrazoline derivatives on cyclooxygenase and lipoxidase activities.
Robak J; Duniec Z
Biochem Pharmacol; 1982 Jun; 31(11):1955-9. PubMed ID: 6810898
[TBL] [Abstract][Full Text] [Related]
75. Leukotriene B4 activates the NADPH oxidase in eosinophils by a pertussis toxin-sensitive mechanism that is largely independent of arachidonic acid mobilization.
Lindsay MA; Perkins RS; Barnes PJ; Giembycz MA
J Immunol; 1998 May; 160(9):4526-34. PubMed ID: 9574559
[TBL] [Abstract][Full Text] [Related]
76. Effect of inhibitors of arachidonic acid metabolism on corneal reepithelialization in the rat.
Gupta AG; Hirakata A; Proia AD
Exp Eye Res; 1993 Jun; 56(6):701-8. PubMed ID: 8595812
[TBL] [Abstract][Full Text] [Related]
77. Cytochrome P-450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat.
Oyekan AO; McGiff JC; Quilley J
Circ Res; 1991 Apr; 68(4):958-65. PubMed ID: 1901256
[TBL] [Abstract][Full Text] [Related]
78. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors.
Spaethe SM; Snyder DW; Pechous PA; Clarke T; VanAlstyne EL
Biochem Pharmacol; 1992 Jan; 43(2):377-82. PubMed ID: 1310855
[TBL] [Abstract][Full Text] [Related]
79. Complex effects of in vitro hyperoxia on alveolar macrophage arachidonic acid metabolism.
Sporn PH; Murphy TM; Peters-Golden M
Am J Respir Cell Mol Biol; 1990 Jan; 2(1):81-90. PubMed ID: 2155014
[TBL] [Abstract][Full Text] [Related]
80. Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassay and radioimmunoassay.
Zakrzewski JT; Barnes NC; Piper PJ; Costello JF
Br J Clin Pharmacol; 1987 Jan; 23(1):19-27. PubMed ID: 3028454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]